chrisvoncsefalvay/vaers-outcomes huggingface dataset:
cannot bend over/stomach feels like a constant knot; sick to his stomach when he stands; severe nausea; throwing up; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (cannot bend over/stomach feels like a constant knot), ABDOMINAL PAIN UPPER (sick to his stomach when he stands), NAUSEA (severe nausea) and VOMITING (throwing up) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced ABDOMINAL DISCOMFORT (cannot bend over/stomach feels like a constant knot), ABDOMINAL PAIN UPPER (sick to his stomach when he stands), NAUSEA (severe nausea) and VOMITING (throwing up). The patient was treated with DIMENHYDRINATE (DRAMAMINE) at a dose of 1 dosage form; SIMETICONE (ALKA SELTZER ANTI GAS) at a dose of 1 dosage form and SIMETHICONE at a dose of 1 dosage form. At the time of the report, ABDOMINAL DISCOMFORT (cannot bend over/stomach feels like a constant knot), ABDOMINAL PAIN UPPER (sick to his stomach when he stands), NAUSEA (severe nausea) and VOMITING (throwing up) outcome was unknown.            Concomitant product information, if any, was not provided by the reporter. Other treatment medications include some liquid for nausea, ginger ale  Action taken with mRNA-1273 in response to the event was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Addition information added include reporter contact details
A 17 year old female was given 0.25ml Moderna booster as their third dose. Patient had originally gotten Pfizer as first and second dose as they are not eligible for Moderna given their age.  No known adverse event aside from being given the incorrect booster based on patients age.
Patient received 1st dose of COVID vaccine. After she received the vaccine, she stated she had a scratchy throat, was flushed and coughing. I administered 25mg of Benadryl orally. Patient denied symptoms or worsening signs. I had the patient wait 30 minutes. Afterwards, patient denied any other issues or symptoms. I received the phone number for the patient, however the number is from another country. I tried calling the patient with no answer. Will attempt to follow-up tomorrow.
Erythema of extremities; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (Erythema of extremities) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced ERYTHEMA (Erythema of extremities). At the time of the report, ERYTHEMA (Erythema of extremities) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. No treatment was reported.
She woke up having a blister in the part after where she got administered the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A female patient received bnt162b2 (BNT162B2), administration date 21Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE VESICLES (non-serious) with onset Mar2021, outcome "unknown", described as "She woke up having a blister in the part after where she got administered the vaccine". Additional information: Reporter's mother who is having side effects after first dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
9/3/2020 into 9/4/2020: Pt developed swelling in left arm. Swelling subsided and then red rash appeared. Rash was treated with Benadryl cream. It has improved.
Diarrhea; Received their first dose of the Pfizer covid vaccine (adult dose from Gray cap); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 7 year-old female patient received bnt162b2 (BNT162B2), administration date 16Dec2021 (Lot number: FH8020) at the age of 7 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious) with onset 16Dec2021, outcome "unknown", described as "Received their first dose of the Pfizer covid vaccine (adult dose)"; DIARRHOEA (non-serious) with onset 17Dec2021, outcome "not recovered", described as "Diarrhea". Therapeutic measures were not taken as a result of diarrhoea.  Additional information: Reporter stated that 3 patients received their first dose of the Pfizer covid vaccine (adult dose). First patient: 7 years old female  experiencing diarrhea- lot number FH8020. Second patient: 10 years old male, lot number FH8020 (brother of the female). Third Patient :11 years male - lot number FL0007. Caller wanted to know any recommendation on what to tell the patient regarding what they need to look for. She stated she will be reaching out to disease control as well. Reporter stated the children were 11 and 10.5  and the third child was 7 and 60 pounds, she didn't know what weight pulls in to this. Caller states that she has talked to the parents and notified them. Caller states she is calling to report this and find out what else they should do and what guidelines they need to follow. Reporter stated she had the nurse check in with the patient's parents and they reported this morning she was having a lot of diarrhea but no vomiting and they were pumping her full of fluids.  No follow-up attempts are possible. No further information is expected. .; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101815734 same reporter/drug, different patients.;US-PFIZER INC-202101815735 same reporter/drug, different patients
pt recv vax 3AUG95 & 21OCT97 pt devel approx 10-20 fluid filled rash that crusted over in about 5 days;
Within 15-30 min of receiving immunizations, patient had a 1-2 minute episode of eyes rolling, decreased responsiveness to voice and pain, no obvious seizure activity. ? Syncopal Episode. Pt returned to usual self within several minutes.
Information has been received from a medical assistant, referring a patient of unknown age and gender. Information on medical history, concomitant medications and drug allergies was not provided.   On an unknown date, the patient was vaccinated with a dose of improperly stored PROQUAD (lot# M039448, expiration date 20-MAR-2018) for prophylaxis (dose and route of administration were not reported). The temperature of storage for PROQUAD was above -10 Celsius and below 8 Celsius for 1 hour and 2 minutes (2 excursions). A data logger was involved. There was no previous temperature excursion. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1702USA011638: US-009507513-1706USA000480: US-009507513-1706USA000481: US-009507513-1703USA002284: US-009507513-1706USA000487: US-009507513-1706USA000488: US-009507513-1706USA000489: US-009507513-1706USA000490: US-009507513-1706USA000491: US-009507513-1706USA000492:
INJECT SITE REACTION (SWELLING, REDNESS, HEAT, ITCHING).
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 20-JUL-2017 the patient was vaccinated with an improperly stored dose of M-M-R II (lot number M010426 expiration date: 01-MAR-2018, lot number: M032157 expiration date: 01-JUL-2018, lot number: M039913 expiration date: 26-SEP-2018) for prophylaxis (digital data logger). Concomitant therapies included sterile diluent (MRK). No adverse effects reported. Sender's Comments: US-009507513-1708USA002800.
Impact on menstrual cycle which resulted in a significant changes including cramps and heavy bleeding.  Given that I have heard of several teens in this age group having their menstrual cycle impacted after this vaccination, I felt it was very important to report this.  While this is manageable for my daughter, this seems to be an obvious side effect that is not being excluded from any literature about this vaccine.
Less than 24 hours post injection, pt c/o /fatigue, body aches, & bilat fingertips are tingling. Sx's continued so pt seen in office today (10/12). Reports 5/10 frontal headache, dizziness w/ change of position (orthostatic VS - WNL); denies head or neck trauma appearance smiling, NAD. No numbness or tingling in LE's. No ataxia noted.
This spontaneous report was received from a registered nurse referring to unspecified number of patients of unknown ages and genders. There were not concurrent conditions and medical history reported. On an unknown date, the patients were vaccinated with unspecified and improperly stored doses of PROQUAD (Merck) lot numbers L040414 expiration date 13-APR-2017, albumin status rHA and L033697 expiration date 28-FEB-2017, albumin status rHA (route, dose, dose number and anatomical place of vaccination were not provided). No adverse effects were reported. Temperature/time frame: 30-JAN-2016 -14 degrees C for 4 hours; 01-FEB-2016 -14 degrees C for 44 hours and -12 degrees C for 9 hours; 02-FEB-2016 -11 degrees C for 15 hours; -10 degrees C for 9 hours; 03-FEB-2016 -9 degrees C for 15 hours and -8 degrees C for 9 hours; 04-FEB-2016 -7 degrees C for 15 hours and -6 degrees C for 9 hours; 05-FEB-2016 -5 degrees C for 15 hours and -4 degrees C for 9 hours; 08-FEB-2016 -3 degrees C for 63 hours. Cumulative -10 degrees C to -14 degrees C for 81 hours (unlimited range) and cumulative -9 degrees C to -3 degrees C for 135 hours. No previous temperature excursion. No product quality complaint was involved. This is one of several reports received from the same source. Additional information has been requested.
Says had temp of 100.5, chills, fever and pain in arm on 3/24/10. Today say feels ok. Temp. 98.6, says tired but appetite normal. See DDC, DAE-a BR 3/25/10.
Tightness in chest, extreme nausea, dizziness, headache, shortness of breath. After receiving the vaccine I had these symptoms for the rest of the day, as of this writing I am still feeling mostly nausea and the tightness in my chest has died down.
Diagnosed withPolymyalgia Rheumatica and a  high SED rate of 117, severe joint pain in shoulders, neck, wrists, fingers, ankles, and feet. First diagnosed January 12, 2022 but symptoms were first noticed December 6,2021 and thought to be a sever attack of Rheumatoid Arthritis. Pain on scale of 1-10 stared at 6 but increased over time to a 10 and continued until patient went to PCP, Doctor on January 12th. Lab results showed a SED Rate of 117. Doctor diagnosed the condition as Polymyalgia Rheumatica. Put on 10 MG of Prednisone for two weeks. Condition did not improve so after 1 month on this level of Prednisone, dose increased to 20 MG and the condition is starting to improve.
SWELLING NEAR INJECTION SITE, BUT NOT AT IT. HARD SWOLLEN SPOT. NOT HOT, NOT RED.
The next day 12/28/2021 after the third dose of vaccine, had fever around 101-103F for 2 days and half, took Tylenol to reduce the fever. But I keep had low fever around 99F every night, neck pain and headache for about 2 weeks, then I went to see urgent care on 1/14/2021, did blood test, and it was normal, and will do another ultrasound next week. After the urgent visit, I started having higher fever again around 100-101F since noon, not evening anymore, same neck pain and headache, I went to medical center emergency on 1/18/2021, did another blood test, chest xray and urinalysis, and the doctor diagnosed I had urethritis which I didn't agree with because I have no related symptom, and prescribed me "Cefalexin" which I have been taking for almost one week with no cure, and I still having fever every day.
The vaccine was administered incorrectly.  The IM injection was given too high on the left arm.  The injection immediately caused significant pain in the left shoulder which worsened throughout the day and into the following day.  The significant pain in the left shoulder has persisted and is accompanied by decreased AROM, decreased strength, and sleep disruption.  Treated with Ibuprofen 800mg q8h and ice with minimal benefit.  Saw PCP on 01/29/2021 who recommended continuation of same and ordered a PT referral.  Was unable to work for 3 days due to this complication.
5 days after receiving immunization arm began to ache.  Pain has worse-arm feels weak.  Sleeps with arm flexed to body for comfort.  1 week after vaccine bilat thigh pain/ach/fatigue thigh symptoms resolved in 3 days.
Received the nasal vacine on 11/13 though child is asthmatic.  Began coughing in the am of 11/14.  Was taken to the hospital at 2:30 am on 11/15 with difficulties in breathing and low grade fever.  Was admitted at 7:00 am.  Was released from hospital at noon on 11/16.  Is taking Predisone and Albuterol at home.  Has not returned to school yet.  1/20 and 11/24 Medical records and discharge summary received for DOS 11/15-11/16. Final DX: Reactive airway disease exacerbation improved.  Viral upper respiratory infection C/O Difficulty breathing.  cough, congestion. hypoxia, fever.  Wheezing  12/7/09 Duplicate records from prev. entered dates. No update to VAERS report.
Information has been received from a public health nurse concerning a pt who in September, 2000 was vaccinated with a dose of varicella virus vaccine live (Lot # 632727/0089K).  Subsequently, the pt developed chickenpox breakthrough. It was noted that this case was part of 4 cases of chickenpox breakthrough one of which was "mild" and the other three were "regular chickenpox". Unspecified medical attention was sought. Subsequently, all cases resolved. There was no product quality complaint involved. The reporter also mentioned three other pt's who developed chickenpox breakthrough and experienced similar reactions (WAES # 0403USA00650, 0403USA01867, 0403USA01868).  Additional information has been requested.
Redness at the site of injection; Swollen injection site; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of   in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 28-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment for the event included loratadine.  Case comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
These symptoms did not exist until after vaccination. Uveitis, mesenteric panniculitis and marker for Bechet's syndrome in blood tests.  Pericardial cyst first noted in 2010 at 4 cm.  Grew to 7.7 cm in June 2021 and 9.0 cm in September 2021.  All finding from CT Scan's.
One day after patient received both Shingrix and Pneumovax vaccines, he felt ill with flu-like symptoms and didn't eat much. By Monday, he had to leave work because of feeling ill and went to his doctor. The doctor said his BP was low (96/70) and he was very lethargic. He threw up at work on Monday and the MD sent him to urgent care to get rehydrated. He drank a glass of water at the MD and by the time he went to the urgent care, he felt better and did not require any IV hydration.  His arm was very sore, but it was his left arm which rec'd the Pneumovax vaccine.
I had received mosquito bites on my leg a week before I received the first dose of the COVID vaccine. These bug bites were not itching and almost gone when I received the vaccine, however, the night after my vaccine they became very itchy. The next morning, the bites had swelled up, were very hot, itchy and unbearable to manage. They were treated with at home-remedies and over the counter itch medicine. They are almost gone again as of the 27th of April. I took various pictures when they swelled up. My partner received the Johnson and Johnson vaccine and also said his bug bites became itchy for the first time since he got the bite.
Patient received Pfizer vaccine for 5-11yo, but was only 3years 10 months old at time of vaccination
o       Staff Member (LPN) received Dose 1 of Pfizer COVID vaccine on Tuesday, 12/29 during clinic at Nursing Home  o       Patient started to experience soreness in arm at injection site that day, and continued to work her shift.  No mention to our team during clinic.  o       Woke up Tuesday am with a stiff neck on left side (same as injection side), and thought maybe she had slept on it incorrectly.  Took Ibuprofen  o       Went to work and pain started to increase, and left work around 2:00pm on Wednesday, 12/30.  Pain went from arm to shoulder, to neck up to ear.  o       At approximately 2am on 12/31/2020, the pain had increased.  Patient self-administered a half of Norco table (strength currently unknown) that was prescribed to her.  o       At approximately 5am, patient had her daughter drive her to Emergency Room, due to increased pain that was to level almost bringing her to tears.  o       According to patient, the physician at hospital administered an injection of morphine and a muscle relaxant.  o       Patient is currently home, and states feels 100% better.
The patient received the vaccine at approximately 1:00pm.  During the standard observation time, the patient reported that she developed palpitations, dizziness, and headache.  She was transferred to the urgent care clinic within the health center approximately 1 hour after receiving the vaccine (2:00pm).  Upon arrival to urgent care, the palpitations had resolved, but she continued to have a headache.  An EKG was done, and did not demonstrate any acute issues.  She was observed in urgent care and discharged home about 2 hours later (4:00pm).
I started feeling achy in the beginning and it started to get worse as time went on. I then started to developed a cough, congestion, headache, and a slight fever. This lasted for about 4 or 5 days and then the symptoms started to dim down a little. I was taking ibuprofen and over the counter decongestion medication. This was the most intense side effects of a vaccine I had from a vaccine, and I contracted COVID still after taking them.
Pt developed severe fatigue, nausea with abdominal pain, and subjective complaint of weakness after her 2nd  dose of Gardasil (seen 1st 3/27/07 for this problem). Symptoms have persisted since that time.
No additional AEs or PQC reported; VARIVAX was administered on 8/14/2023 and MMR II was administered on 9/5/2023.; This spontaneous report was received from nurse and refers to a patient of unknown age and gender.  The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 14-AUG-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX), lot #W031815 (expiration date not reported, but upon internal validation established as 05-OCT-2024), and then on 05-SEP-2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), lot #W034592 (expiration date not reported, but upon internal validation established as 10-MAY-2024) (Inappropriate schedule of product administration), both administered for prophylaxis (strength, dose, frequency and route of administration were not provided for both). No other information was provided. No additional adverse events (AEs) or product quality complaints (PQC) were reported.
Narrative:  Patient experienced diarrhea one day after receiving the first dose of the COVID-19 vaccine. Patient visited the emergency department to seek treatment for the adverse reaction and received loperamide 2 mg PO four times daily for diarrhea. Symptoms improved after a few days of treatment.
Diarrhea  vomiting  dizzy fatigue arm pain  sore throat....last for 5 days
Fevers from 99.6-101.6 for about 15 hours. Aches, lethargy, chills, and fatigue for about 24 hours. Brain fog for the subsequent 24 hours.
Rash and knot size of quarter to upper R arm at injection site after receiving vaccines. Recommended cool compress to affected site and iburprofen PRN.
Has been nauseated and throwing up; Has been nauseated and throwing up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2), administration date 24Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious), VOMITING (non-serious) all with onset 24Mar2021, outcome "unknown" and all described as "Has been nauseated and throwing up".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
ITICHING, BURNING, HURTING, BRUISE AT SITE. FEVER  OF 102.2 FOR 2 DAYS, RED BUMPS  ON TRUNK OF BODY
Information has been received concerning a 7 year old female with no concurrent conditions or pertinent medical history who on 28-OCT-2008 received a booster of VARIVAX vaccine (Oka/Merck). Concomitant therapy included influenza virus vaccine (unspecified) and hepatitis A virus vaccine (unspecified). On 31-OCT-2008 was noticed 5-6 pustular lesions on chest. On 03-NOV-2008 through 05-NOV-2008 noticed increasing maculopapular rash on chest and some small areas on back. One lesion upper arm. Nothing on face, neck, legs. No fever or any other complaints. Rash itchy, but no painful. The patient sought medical attention. On 5-NOV-2008 the primary pediatrician felt that it was not varicella, possibly shingles- although it crossed dermatomes. The patient was referred to a dermatologist. On 06-NOV-2008 the first dermatologist felt it was shingles, although when another dermatologist was consulted at the same appointment, the patient was diagnosed with poison ivy. The outcome of the patient was not reported. Follow up information was received from the medical assistant who stated that the patient did not have an adverse effect from VARIVAX (Merck). It was determined that the patient had poison ivy. Additional information has been requested.
pt here to received Dose 2 of Moderna covid vaccine. pt is 2 years old. Vax received at Facility (vax clinic held by Covid Mobile Team) Instead of receiving 0.25 ml of Bivalent (6 months+) (Dark Blue Cap / Gray Border), pt received 0.2 ml of Bivalent (6 months - 5 years) (Dark Pink Cap). pt stayed in observation for 15 minutes. per mom, pt was feeling fine.
Temp of 103 and still 101 after administration of acetaminophen. Headache. Body aches. Chills. Sweats. Mild nausea
Immediately after administration of the vaccine the patient experienced swelling and redness at the administration site. An ice pack was applied and patient stayed for an additional 40 min for observation. After 40 min the redness and swelling was greatly improved. patient had no further complaints and was discharged.